East Asian Breast Cancer Genome Atlas and Recurrence Risk Prediction

Recruiting Observational Study
Breast Cancer
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
20 and older
Sex
Any
Study type
Observational
Participants needed
2,000 (estimated)
Sponsor
National Taiwan University Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This project aims to establish the cancer genome atlas and the platform of recurrence risk prediction specific for East Asian breast cancer patients. The study was planned to collect blood sample, fresh tumor tissue, and paraffin embedded tumor tissue from 2000 patients. Aims to identify unique genetic alterations in Asian tumors, to identify the susceptible genes for breast carcinogenesis in East…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * 1\. Aged more than 20-year-old at the time of informed consent. * 2\. An unconfirmed breast tumor, or have histologically confirmed invasive breast cancer. * 3\. Have radiological or objective evidence of breast tumor size ≥1 cm. * 4\. Be able to comply with study procedures t…
Contacts

Yen-Shen Lu, MD, PhD

+886-223123456

yslu@ntu.edu.tw

CONTACT